Reports for CANDESARTAN CILEXETIL
Ingredient
CANDESARTAN CILEXETIL
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ CANDESARTAN PLUS | 12.5MG 16MG | TABLET | Resolved | 2019-01-21 | 2020-08-24 | 73123 |
| SANDOZ CANDESARTAN PLUS | 12.5MG 32MG | TABLET | Resolved | 2019-02-18 | 2020-08-24 | 76110 |
| SANDOZ CANDESARTAN | 8MG | TABLET | Resolved | 2019-03-26 | 2020-08-24 | 79532 |
| SANDOZ CANDESARTAN | 8MG | TABLET | Resolved | 2019-03-26 | 2020-08-24 | 79529 |
| SANDOZ CANDESARTAN | 4MG | TABLET | Resolved | 2019-03-26 | 2020-08-24 | 79524 |
| SANDOZ CANDESARTAN | 32MG | TABLET | Resolved | 2019-03-26 | 2020-08-24 | 79519 |
| SANDOZ CANDESARTAN | 16MG | TABLET | Resolved | 2019-03-26 | 2020-08-24 | 79516 |
| SANDOZ CANDESARTAN | 16MG | TABLET | Resolved | 2019-01-21 | 2020-08-24 | 73116 |
| SANDOZ CANDESARTAN | 16MG | TABLET | Resolved | 2019-03-26 | 2020-08-24 | 79513 |
| SANDOZ CANDESARTAN | 8MG | TABLET | Resolved | 2018-12-24 | 2020-08-24 | 70464 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT CANDESARTAN | 4MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65171 |
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |